It might be of some concern to shareholders to see the Amneal Pharmaceuticals, Inc. ( NASDAQ:AMRX ) share price ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has earned a consensus recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports.

Shares of Amneal Pharmaceuticals stock opened at $8.28 on Tuesday. The firm has a market cap of $2.57 billion, a PE ratio of -12.18 and a beta of 1.05. Amneal Pharmaceuticals has a twelve month ...

Amneal Pharmaceutical LLC, is a global biopharmaceuticals company, is recalling two lots of ropivacaine hydrochloride injection, USP, 500mg/100mL, infusion bags to the hospital/user level as the ...

Californians can now purchase over-the-counter naloxone, an opioid overdose-reversing medication, for $24 a carton, Gov. Gavin Newsom said Monday. The California Department of Health Care Access and ...

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.

BRIDGEWATER, N.J., April 11, 2025--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global biopharmaceutical company, today ...

AMRX insiders have traded $AMRX stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales. Here’s a ...